Background: Carboplatin (cis-diammine 1,1cyclobutanedicarboxylateplatinumII), is an antitumor platinum complex derived from cisplatin. Preclinical studies suggest that it may have greater antitumor activity and lower toxicity than cisplatin. The potential of Carboplatin to induce embryo toxicity was investigated in the albino mice.
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induced by exogenous chemical or physical agents, continues to be a burgeoning area of medical research in the quest for the Teratology, the study of abnormal prenatal development and congenital malformations eradication of preventable birth defects. Identification of agents with teratogenic potential from the plethora of drugs and chemicals that human beings come into contact with in their everyday environment is crucial; although only some 10% of congenital anomalies are thought to be caused by teratogens [1] representing roughly one in every thousand live births, they compromise the quality of life for millions of individuals worldwide and cost billions of dollars in health care every year.
Carboplatin (cis-diammine-1,1 cyclobutanedicarboxylateplatinum II), a second-generation platinum-containing anti-cancer drug, which was developed by Bristol-Myers Company, USA is currently being used in the clinic against lung, ovarian, head, and neck cancers. Cisplatin, a platinum coordinated complex like Carboplatin, has been reported to be embryotoxic in rats [2, 3] and mice [4, 2, 5] and chicks [6] .
This study was performed to evaluate the potential of Carboplatin to induce fetal dysmorphogenesis, prenatal mortality, and intrauterine growth retardation at a dose level of 6 mg/kg body weight in mice fetuses which correspond to the teratogenic dose in the previosly described Bristol-Myres's report for rat fetuses.
MATERIALS AND METHODS

OBSERVATIONS
Out of 198 treated fetuses, 144 were live and 54 were found to be dead. And out of 144 live treated fetuses, 115 fetuses showed congenital malformations [ Table 1 ].
Fetal Mortality: In treated groups, fetal mortality was much more [27.2%] as compared to control where it was zero (Table 1) .
Intrauterine Growth Retardation (IUGR):
Marked growth retardation was observed in Carboplatin treated fetuses as compared to control fetuses (45.1%) (Table 2);[ Figure 5 ].The average weight of control fetuses was 1.414 gm and that of treated group fetuses was 1.071 gm. p-value was found to be < 0.001, which is highly significant (Table 3 & 4);[ Figure 2 ]. Significant decrease in Crown to Rump length (CRL) was observed. The average CRL of control fetuses Forty female albino mice of an average weight of 20 +/-3 gm and an average age of 80-100 days were used in the study from the Institutional Central Animal Research Facility. Animals were kept individually in plastic cages in noise free, air conditioned animal house with temperature maintained at 75°F and on a light dark cycle of 12: 12 hours. Humidity was maintained with a minimum of 50%. Mice were fed on diet pellets (Hindustan Lever Bombay, India), tap water and libitum and treated with utmost humane care. All experiments were designed in strict adherence to the guidelines of the Institutional Animal Ethics Committee. Female albino mice were kept overnight in the same cage with male mice of same stock in the ratio of 3:1 (female:male = 3:1). At 8:00 A.M. in next morning vaginal smear was examined. If vaginal smear was positive, then smear was made on glass slide and examined under light microscope. If sperms were found, pregnancy was confirmed, and it was considered as day ' ZERO' of pregnancy. The pregnant mice were weighted on alternate days and kept individually in separate cages.
Drugs and Chemical:
Commercially available carboplatin BP (trade name Carbowel) was procured from Getwell Oncology Pvt. Ltd.
The animals were randomly assigned to two groups control and treated containing 10 mice and 30 mice respectively and received the following treatments: Mice of control group received disstiled water intraperitoneally on 7 th day of gestation. Mice of treated group received carboplatin 0.012ml (6 mg/kg body weight) intraperitoneally by tuberculin syringe on 7 th day of gestation.
Collection of Fetuses:
The pregnant mice were anesthetized with an overdose of ether on day 19 th of gestation (full term pregnancy). The uterine horns were exteriorized after opening the abdomen by midline caesarean incision. The sacs were inspected for sites of resorptions and viable fetuses. The fetuses were removed from the uterus and were dried on a bloating paper. The weight of fetuses were recorded by electronic weighing balance. Fetuses were examined for external abnormalities and crown to rump length (CRL) was recorded.
was 21.89 mm and that of treated fetuses was 18.87 mm. p-value was found to be < 0.001, which is highly significant (Table 5 & Brain Morphology: Weight and size of brain of control and treated fetuses were taken after dissection. The average weight of control fetuses brain was 0.048 gm and that of treated fetuses brain was 0.038 gm. p-value was found to be < 0.001, which is highly significant (Table 7 & 8);[ Figure 4 ].The average anterior-posterior and transverse diameter of control fetuses brain was 8.06 mm and 4.78 mm respectively and that of treated fetuses brain was 6.42 mm and 3.9 mm respectively. p-value was found to be < 0.001,which is highly significant ( Figure  5 ], 45 fetuses showed intraperitoneal hemorrhage [ Figure 6 ]. On examination of limbs in treated group, 28 fetuses showed angular and torsional deformities [ Figure 7 ]. Forward neck bending was also observed in 21fetuses of treated group [ Figure 8 ]. 
DISCUSSION
The present study has demonstrated that Carboplatin (a platinum based chemotherapeutic agent) when administrated on 7 th day of gestation at a dose of 6 mg/kg body weight is teratogenic to albino mice which includes fetal resorptions / death, intrauterine growth retardation [IUGR] , limb anomalies and other anomalies without significant maternal toxicity.
Shuichi et al (1989) suggested that carboplatin is embryotoxic , inducing intrauterine death and congenital malformations in rats, when injected during the early stages of development i.e. 6 th -8 th day of gestation at a dose level of 6 mg/kg body weight [7] . Teratological effects of carboplatin in mice have not been established till date. In the preceding studies, carboplatin achieved the embryolethal effects when administered before the organogenesis period [8] whereas this drug retarded fetal development but revealed no embryolethality when dosed during the organogenic period [9] . Since cisplatin, one of platinum coordinated complexes, is a bifunctional agent which causes interstrand/intrastrand DNA crosslinking in mammalian cells [10] [11] [12] , its major mechanism has been proposed to be the inhibition of DNA replication due to these crosslinking effects [13] [14] [15] . The mechanism of action of carboplatin seems to be similar to that of cisplatin because of resemblance in the chemical structure between these two compounds. Further, it has been shown that cisplatin-induced embryolethality varies with the stage of gestation [2, 5] . These results suggest that carboplatin administrated to pregnant mice during the pregnancy may induce fetal death and fetal gtowth retardation. Though elevations in the number of dead fetuses during the early gestation period were considered to be predominantly due to the direct effects of carboplatin, secondary effects through dams could not be denied. Carboplatin induced various external malformations when administrated to pregnant mice at 6 mg/kg body weight on 7 th day of gestation. Especially, the incidences of intraperitoneal hemorrhages (31.2%), limb anomalies (19.4%) and neck bending (14.6%) were higher in these fetuses than corresponding controls.
Carboplatin reveals the teratogenic action against mice conceptus when dosed at 6 mg/ kg body weight on 7 th day of gestation. This finding was supported by the fact that a significant elevation in the number of empty implantation sites/fetal death/ resorptions (27.2%), was revealed when carboplatin was injected to pregnant mice at 6 mg/kg body weight on 7 th day of gestation. In the present study, microcephaly was observed as evidenced by the reduction in weight and various dimensions of the brain. As stated by Singh and Padmanabhan [16] central nervous system defects can be induced in experimental animals, by a variety of agents like nutritional deficiency, dietary restrictions, ionizing radiations, maternal viral infections chemicals and therapeutic agents [17] .
They also noted microcephaly and hydrocephaly along with various brain anomalies induced by such agents. This was associated with fetal intrauterine growth retardation [IUGR] . Fetal IUGR and microcephaly due to ischaemia have also been observed by Wigglesworth [18] .The present study also showed IUGR as well as microcephaly. The limb defects and rumplesness observed in the present study can be explained by the fact that these mesodermal elements require neuroectodermal tissues for induction. The damage of neuroectodermal tissues must have failed to induct the mesoderm to proceed for proper development of these skeletal elements. The highest death rate of the embryos (from 25% to 100% ) due to exposure to the tested agents was observed in the periods of embryogenesis when embryos are most susceptible to adverse factors (days 4 to 6 of embryodevelopment in the stage of blastogenesis). The teratogenic effects of the tested agent was observed only during the period of organogenesis (day 7, 10 and 14, in the stage of organogenesis).
CONCLUSION
Statistically significant incidence of severe malformations which includes increase fetal mortality in dams and delayed fetal development in surviving conceptuses were observed in this study. Fetal mortality and intrauterine growth retardation (IUGR) was much more in the treated group as compared to control. Various external malformations including deformities of limb, neck bending and intraperitoneal hemorrhage were also observed in carboplatin treated group.These external deformities were mostly due to abnormal development of appendicular skeleton. Thus, the present study establishes the drug to be teratogenic as well as lethal in developing mice embryos.
